Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Shanghai Junshi Biosciences (688180 CH)
Watchlist
88
Analysis
Health Care
•
China
Shanghai Junshi Biosciences Co., Ltd. operates as a biopharmaceutical company. The Company develops and sells small molecule drugs, antibody drug conjugates, and other products. Shanghai Junshi Biosciences markets its products worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Shengyi Electronics
•
26 Aug 2025 07:05
STAR50/STAR100 Index Rebalance Preview: Outright Changes & Migrations
The STAR50/100 forecast adds have outperformed the forecast deletes over the last month, and by a lot. Announcement is at the close on Friday, so...
Brian Freitas
Follow
1k Views
Share
bearish
•
Quantitative Analysis
•
10 Aug 2025 10:15
A-H Premium Weekly (Aug 8th): Metallurgical Corporation Of China, Shandong Gold Mining
We analyzed A-H premium changes in the past week and highlight A-H premium changes for Metallurgical Corporation Of China, Shandong Gold Mining,...
Ke Yan, CFA, FRM
Follow
619 Views
Share
bullish
•
Quantitative Analysis
•
22 Jun 2025 10:15
A-H Premium Weekly (Jun 20th): Petrochina, Shanghai Junshi Biosciences, China Oilfield Services
We analyzed A-H premium changes in the past week and highlight A-H premium changes for Petrochina, Shanghai Junshi Biosciences, China Oilfield...
Ke Yan, CFA, FRM
Follow
406 Views
Share
bearish
•
Quantitative Analysis
•
15 Jun 2025 10:10
A-H Premium Weekly (Jun 13th): Tigermed, Bank Of Chongqing, Sinopec Oilfield Service
We analyzed A-H premium changes in the past week and highlight A-H premium changes for Tigermed, Bank Of Chongqing, Sinopec Oilfield Service,...
Ke Yan, CFA, FRM
Follow
528 Views
Share
bearish
•
Quantitative Analysis
•
08 Jun 2025 10:15
A-H Premium Weekly (Jun 6th): Jiangsu Expressway, Sichuan Expressway, CICC
We analyzed A-H premium changes in the past week and highlight A-H premium changes for Jl Mag Rare-Earth, Jiangsu Expressway, Sichuan Expressway,...
Ke Yan, CFA, FRM
Follow
457 Views
Share
First
Previous
4
5
6
7
8
9
10
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x